Press release
PEGylated Proteins Market Grow at CAGR of 10.16% During 2023-2028
According to IMARC Group's latest research report, titled "PEGylated Proteins Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028," the global PEGylated proteins market size reached US$ 1.16 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 2.13 Billion by 2028, exhibiting a growth rate (CAGR) of 10.16% during 2023-2028.Get a Free Sample Copy of Report at - https://www.imarcgroup.com/pegylated-proteins-market/requestsample
PEGylated Proteins Market Outlook:
PEGylated proteins are protein molecules that are conjugated with polyethylene glycol (PEG). Its process involves modifying the surface of proteins in order to extend their half-lives and improve their solubility, stability, and bioavailability. The process covalently attaches one or more PEG molecules to the surface of a protein, resulting in a larger, more hydrophilic molecule. The PEG molecules act as a protective shield, shielding the protein from enzymatic degradation, reducing immunogenicity, and enhancing the pharmacokinetic properties of the protein. Additionally, PEGylated proteins are widely used in biopharmaceuticals due to their improved pharmacokinetic properties and extended half-lives, allowing for longer action duration and improved therapeutic efficacy. They are adopted in gene therapy and vaccine delivery as they provide a promising platform for the development of new therapeutic agents to treat a wide range of diseases.
Browse Full Report With TOC: https://www.imarcgroup.com/pegylated-proteins-market
PEGylated Proteins Market Trends:
The escalating healthcare expenditure majorly drives the global market. This can be supported by the growing number of chronic illnesses, such as kidney disorders, autoimmune diseases, genetic disorders, hepatitis, and rheumatoid arthritis, among individuals. Along with this, PEGylated proteins are extensively employed to treat inflammation, deliver corrective genes to cells, prevent blood clots, deliver growth hormones, and check the progression of chronic kidney disease is a major driving factor. Additionally, the rising use of PEGylated proteins in cancer treatment to deliver chemotherapy drugs directly to cancer cells and decrease the side effects on healthy cells is impacting the market favorably. Apart from this, continuous advancements in PEGylation technology, such as the development of new PEGylation techniques that can generate smaller and more complex molecules, are creating a positive market outlook. Some of the other factors driving the market include the rising aging population and the implementation of various government initiatives to boost regulatory standards in the pharmaceutical industry.
Key Market Segmentation:
Competitive Landscape with Key Players:
• Abcam plc
• Biomatrik Inc.
• Creative PEGWorks
• Iris Biotech GmbH
• JenKem Technology USA Inc.
• Laysan Bio Inc.
• NOF America Corporation (NOF Corporation)
• Profacgen
• Thermo Fisher Scientific Inc.
Product Insights:
• Consumables
• PEGylation Reagents
• PEGylation Kits
• Services
Protein Type Insights:
• Colony Stimulating Factors
• Interferons
• Erythropoietin
• mAbs
• Recombinant Factor VII
• Others
Application Insights:
• Cancer Treatment
• Hepatitis
• Chronic Kidney Diseases
• Hemophilia
• Multiple Sclerosis
• Gastrointestinal Disorders
• Others
End User Insights:
• Pharmaceutical and Biotechnology Companies
• Contract Research Organizations
• Academic and Research Institutes
Breakup by Region:
• North America (United States, Canada)
• Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)
Key Highlights of the Report:
• Market Performance (2017-2022)
• Market Outlook (2023-2028)
• Porter's Five Forces Analysis
• Market Drivers and Success Factors
• SWOT Analysis
• Value Chain
• Comprehensive Mapping of the Competitive Landscape
Browse the Latest Research Report:
• https://www.imarcgroup.com/intelligent-transport-systems-market
• https://www.imarcgroup.com/pulse-oximeter-market
• https://www.imarcgroup.com/metal-packaging-market
• https://www.imarcgroup.com/plant-based-meat-market
• https://www.imarcgroup.com/ceramic-sanitary-ware-market
• https://www.imarcgroup.com/heparin-market
• https://www.imarcgroup.com/indian-sanitary-napkin-market
• https://www.imarcgroup.com/bakery-ingredients-market
Contact us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
About us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organisations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release PEGylated Proteins Market Grow at CAGR of 10.16% During 2023-2028 here
News-ID: 2984319 • Views: …
More Releases from IMARC Group

Geo-Textile Manufacturing Plant Setup Cost 2025: CapEx/OpEx Analysis with Profit …
Setting up a geo-textile manufacturing facility necessitates a detailed market analysis alongside granular insights into various operational aspects, including unit processes, raw material procurement, utility provisions, infrastructure setup, machinery and technology specifications, workforce planning, logistics, and financial considerations.
IMARC Group's report titled "Geo-Textile Manufacturing Plant Project Report 2025: Industry Trends, Plant Setup, Machinery, Raw Materials, Investment Opportunities, Cost and Revenue" offers a comprehensive guide for establishing a geo-textile manufacturing plant, covering…

Cashew Butter Manufacturing Plant Report 2025: Raw Materials, Investment Opportu …
Cashew butter is a creamy spread made by grinding roasted cashew nuts into a smooth paste, often enhanced with a pinch of salt or sweeteners. It is rich in healthy fats, protein, vitamins, and minerals, making it a nutritious alternative to traditional spreads like peanut butter. Cashew butter is widely used as a spread, in smoothies, baked goods, and health-focused recipes, gaining popularity among health-conscious consumers, vegans, and those seeking…

Calcium Chloride Anhydrous Production Cost Report 2025: Plant Setup Economics an …
Setting up a calcium chloride anhydrous production facility necessitates a detailed market analysis alongside granular insights into various operational aspects, including unit processes, raw material procurement, utility provisions, infrastructure setup, machinery and technology specifications, workforce planning, logistics, and financial considerations.
IMARC Group's report titled "Calcium Chloride Anhydrous Production Cost Analysis Report 2025: Industry Trends, Plant Setup, Machinery, Raw Materials, Investment Opportunities, Cost and Revenue" offers a comprehensive guide for establishing a…

Paper Bag Manufacturing Plant Cost Report 2025: Layout, Machinery, Raw Materials …
Setting up a paper bag manufacturing facility necessitates a detailed market analysis alongside granular insights into various operational aspects, including unit processes, raw material procurement, utility provisions, infrastructure setup, machinery and technology specifications, workforce planning, logistics, and financial considerations.
IMARC Group's report titled "Paper Bag Manufacturing Plant Project Report 2025: Industry Trends, Plant Setup, Machinery, Raw Materials, Investment Opportunities, Cost and Revenue" offers a comprehensive guide for establishing a paper bag…
More Releases for PEG
Biopharma PEG Delivers Innovative PEG Solutions for Enhanced Drug Efficacy
Watertown, MA - October 24, 2024 - Biopharma PEG is excited to announce its extensive offerings of polyethylene glycol (PEG) products, including monofunctional, homobifunctional, heterobifunctional, and multi-arm PEGs, tailored for PEGylation in biopharmaceutical applications. With over 40 PEGylated drugs approved globally, the role of PEGylation in drug development is more critical than ever.
PEGylation provides numerous advantages, such as improved solubility, enhanced stability, and increased circulation time in the bloodstream. By…
Biopharma PEG Expands Multi-Arm PEG Product Line
Biopharma PEG, a leader in PEG derivatives, is excited to announce the expansion of its high-purity Multi-Arm PEG linker product line, catering to the evolving needs of the medical and bioorganic fields. These advanced PEG linkers are available in various functional groups and molecular weights ranging from 1k to 40k, offering unmatched versatility and performance for research and development in cutting-edge medical applications.
"Biopharma PEG is committed to delivering high-purity multi-arm…
Biopharma PEG Supplies PEG Products Used For Infectious Disease Vaccines
As of January 1, 2023, global vaccine development includes a total of 966 vaccine candidates, of which 23% (220) are traditional inactivated or attenuated vaccines. Advances in molecular technology have facilitated the development of other platforms, such as recombinant protein vaccines, nucleic acid vaccines, and viral vector vaccines, which have further diversified global vaccine development.
Recombinant protein vaccines accounted for the largest proportion of all pipeline in development, 22% (215), due…
Biopharma PEG Supplies PEG Products For Click Chemistry Reactions
What is "click chemistry"? "Click Chemistry", this is a literary name given to this kind of reaction by the Nobel Prize winner K.Burry Sharless, when the cards are put together, "click" (click). Simply put, it is to add two structures to two molecules respectively, and these two structures can be specifically combined to synthesize the required chemical molecules. One of the most famous click-chemistry reactions is the Cu-catalyzed azide-alkyne cycloaddition…
Biopharma PEG Develops PEG Linkers for Antibody Drug Conjugates
Antibody-drug conjugate (ADC) is one of the fastest growing fields in tumor therapy, which consists of monoclonal antibody (Antibody), linker (Linker) and active drug (Payload). So far, there are only 15 drugs on the market in the world. However, with the development of some perfect antibody modification techniques, advanced site-specific coupling techniques and powerful small-molecule toxins, ADC drug research has mushroomed and a large number of ADC drugs are in…
Biopharma PEG Provides Multi-arm PEG Derivatives Crosslinked Into Hydrogels
Polyethylene (ethylene glycol) is a hydrophilic polymer that can have a very high water content when cross-linked into a network. Polyethylene glycol (PEG) is a suitable material for biological applications because it does not normally elicit an immune response. Since the 1970s, PEG has been used to modify therapeutic proteins and peptides in order to increase their solubility, reduce their toxicity, and prolong their cyclic half-lives. In the late 1970s,…